Kidney Medicine Internal Medicine

Double Targeting of B Cells and Plasma Cells Using Low-Dose Obinutuzumab and Daratumumab in a Cohort of Severe Resistant Primary Focal Segmental Glomerulosclerosis, Idiopathic Membranous Nephropathy, and Lupus Nephritis

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →